Irisin, two years later

International Journal of Endocrinology

Volumn 2013, Issue , 2013, Pages

  Novelle, Marta G ^a,b   Contreras, Cristina ^a,b   Romero Picó, Amparo ^a,b   López, Miguel ^a,b   Diéguez, Carlos ^a,b  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; IRISIN; SIMVASTATIN; UNCLASSIFIED DRUG;

AEROBIC EXERCISE; ARTICLE; CELL DIFFERENTIATION; CELL METABOLISM; CENTRAL NERVOUS SYSTEM; CHRONIC KIDNEY DISEASE; ENDURANCE TRAINING; ENERGY EXPENDITURE; FAT MASS; HEART FAILURE; HUMAN; INSULIN RESISTANCE; NERVOUS SYSTEM DEVELOPMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; RESISTANCE TRAINING; THERMOGENESIS;

EID: 84888861020     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2013/746281     Document Type: Article

References (63)

1. Kopelman P. G., Obesity as a medical problem. Nature 2000 404 6778 635 643 2-s2.0-0034611791 (Pubitemid 30205068)
2. Mitchell N. S., Catenacci V. A., Wyatt H. R., Hill J. O., Obesity: overview of an epidemic. Psychiatric Clinics of North America 2011 34 4 717 732 2-s2.0-81355164063 10.1016/j.psc.2011.08.005
3. Strasser B., Physical activity in obesity and metabolic syndrome. Annals of the New York Academy of Sciences 2013 1281 141 159 10.1111/j.1749-6632.2012. 06785.x
4. Pedersen B. K., Åkerström T. C. A., Nielsen A. R., Fischer C. P., Role of myokines in exercise and metabolism. Journal of Applied Physiology 2007 103 3 1093 1098 2-s2.0-34548449306 10.1152/japplphysiol.00080.2007 (Pubitemid 47358897)
5. Pedersen B. K., Febbraio M. A., Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nature Reviews Endocrinology 2012 8 457 465 2-s2.0-84859095015 10.1038/nrendo.2012.49
6. Cypess A. M., Lehman S., Williams G., Tal I., Rodman D., Goldfine A. B., Kuo F. C., Palmer E. L., Tseng Y., Doria A., Kolodny G. M., Kahn C. R., Identification and importance of brown adipose tissue in adult humans. New England Journal of Medicine 2009 360 15 1509 1517 2-s2.0-64349105205 10.1056/NEJMoa0810780
7. Nedergaard J., Bengtsson T., Cannon B., Unexpected evidence for active brown adipose tissue in adult humans. American Journal of Physiology 2007 293 2 E444 E452 2-s2.0-34547631960 10.1152/ajpendo.00691.2006 (Pubitemid 47205086)
8. van Marken Lichtenbelt W. D., Vanhommerig J. W., Smulders N. M., Drossaerts J. M. A. F. L., Kemerink G. J., Bouvy N. D., Schrauwen P., Teule G. J. J., Cold-activated brown adipose tissue in healthy men. New England Journal of Medicine 2009 360 15 1500 1508 2-s2.0-64349095231 10.1056/NEJMoa0808718
9. Virtanen K. A., Lidell M. E., Orava J., Heglind M., Westergren R., Niemi T., Taittonen M., Laine J., Savisto N., Enerbäck S., Nuutila P., Functional brown adipose tissue in healthy adults. New England Journal of Medicine 2009 360 15 1518 1525 2-s2.0-64349123664 10.1056/NEJMoa0808949
10. Cannon B., Nedergaard J., Brown adipose tissue: function and physiological significance. Physiological Reviews 2004 84 1 277 359 2-s2.0-0347989317 10.1152/physrev.00015.2003 (Pubitemid 38054374)
11. Puigserver P., Wu Z., Park C. W., Graves R., Wright M., Spiegelman B. M., A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 1998 92 6 829 839 2-s2.0-0032549811 10.1016/S0092-8674(00) 81410-5 (Pubitemid 28155321)
12. Uldry M., Yang W., St-Pierre J., Lin J., Seale P., Spiegelman B. M., Complementary action of the PGC-1 coactivators in mitochondrial biogenesis and brown fat differentiation. Cell Metabolism 2006 3 5 333 341 2-s2.0-33646124709 10.1016/j.cmet.2006.04.002
13. Villena J. A., Carmona M. C., Rodriguez de la Concepción M., Rossmeisl M., Viñas O., Mampel T., Iglesias R., Giralt M., Villarroya F., Mitochondrial biogenesis in brown adipose tissue is associated with differential expression of transcription regulatory factors. Cellular and Molecular Life Sciences 2002 59 11 1934 1944 2-s2.0-0036866036 10.1007/PL00012516 (Pubitemid 36015866)
14. Wu Z., Puigserver P., Andersson U., Zhang C., Adelmant G., Mootha V., Troy A., Cinti S., Lowell B., Scarpulla R. C., Spiegelman B. M., Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 1999 98 1 115 124 2-s2.0-0033538473 10.1016/S0092- 8674(00)80611-X (Pubitemid 29331201)
15. Baar K., Wende A. R., Jones T. E., Marison M., Nolte L. A., Chen M., Kelly D. P., Holloszy J. O., Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1. FASEB Journal 2002 16 14 1879 1886 2-s2.0-0036903174 10.1096/fj.02-0367com (Pubitemid 35462607)
16. Pilegaard H., Saltin B., Neufer D. P., Exercise induces transient transcriptional activation of the PGC-1 α gene in human skeletal muscle. Journal of Physiology 2003 546 3 851 858 2-s2.0-0037322888 10.1113/jphysiol. 2002.034850 (Pubitemid 36204518)
17. Jäer S., Handschin C., St-Pierre J., Spiegelman B. M., AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1 α Proceedings of the National Academy of Sciences of the United States of America 2007 104 29 12017 12022 2-s2.0-34547545892 10.1073/pnas.0705070104 (Pubitemid 47185622)
18. Russell A. P., Feilchenfeldt J., Schreiber S., Praz M., Crettenand A., Gobelet C., Meier C. A., Bell D. R., Kralli A., Giacobino J., Dériaz O., Endurance training in humans leads to fiber type-specific increases in levels of peroxisome proliferator-activated receptor- γ coactivator-1 and peroxisome proliferator-activated receptor- α in skeletal muscle. Diabetes 2003 52 12 2874 2881 2-s2.0-10744228606 10.2337/diabetes.52.12.2874 (Pubitemid 37466855)
19. Wenz T., Rossi S. G., Rotundo R. L., Spiegelman B. M., Moraes C. T., Increased muscle PGC-1 α expression protects from sarcopenia and metabolic disease during aging. Proceedings of the National Academy of Sciences of the United States of America 2009 106 48 20405 20410 2-s2.0-73949099327 10.1073/pnas.0911570106
20. Boström P., Wu J., Jedrychowski M. P., Korde A., Ye L., Lo J. C., Rasbach K. A., Boström E. A., Choi J. H., Long J. Z., Kajimura S., Zingaretti M. C., Vind B. F., Tu H., Cinti S., Højlund K., Gygi S. P., Spiegelman B. M., A PGC1- α -dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 2012 481 7382 463 468 2-s2.0-84856218208 10.1038/nature10777
21. Xu X., Ying Z., Cai M., Xu Z., Li Y., Jiang S. Y., Tzan K., Wang A., Parthasarathy S., He G., Rajagopalan S., Sun Q., Exercise ameliorates high-fat diet-induced metabolic and vascular dysfunction, and increases adipocyte progenitor cell population in brown adipose tissue. American Journal of Physiology 2011 300 5 R1115 R1125 2-s2.0-79955755051 10.1152/ajpregu.00806.2010
22. Ferrer-Martínez A., Ruiz-Lozano P., Chien K. R., Mouse PeP: a novel peroxisomal protein linked to myoblast differentiation and development. Developmental Dynamics 2002 224 2 154 167 2-s2.0-0035988932 10.1002/dvdy.10099 (Pubitemid 34569057)
23. Teufel A., Malik N., Mukhopadhyay M., Westphal H., Frcp1 and Frcp2, two novel fibronectin type III repeat containing genes. Gene 2002 297 1-2 79 83 2-s2.0-0037019815 10.1016/S0378-1119(02)00828-4 (Pubitemid 35217782)
24. Erickson H. P., Irisin and FNDC5 in retrospect: an exercise hormone or a transmembrane receptor? Adipocyte 2013 2 289 293 10.4161/adip.26082
25. Roca-Rivada A., Castelao C., Senin L. L., Landrove M. O., Baltar J., Belen C. A., Seoane L. M., Casanueva F. F., Pardo M., FNDC5/irisin is not only a myokine but also an adipokine. PLoS One 2013 8 e60563
26. Spiegelman B. M., Banting lecture 2012: regulation of adipogenesis: toward new therapeutics for metabolic disease. Diabetes 2013 62 6 1774 1782 10.2337/db12-1665
27. Pedersen L., Hojman P., Muscle-to-organ cross talk mediated by myokines. Adipocyte 2012 1 3 164 167 10.4161/adip.20344
28. Raschke S., Eckel J., Adipo-myokines: two sides of the same coin-mediators of inflammation and mediators of exercise. Mediators of Inflammation 2013 2013 16 320724 10.1155/2013/320724
29. Huang Z., Chen X., Chen D., Myostatin: a novel insight into its role in metabolism, signal pathways, and expression regulation. Cellular Signalling 2011 23 9 1441 1446 2-s2.0-79958767884 10.1016/j.cellsig.2011.05.003
30. Shan T., Liang X., Bi P., Kuang S., Myostatin knockout drives browning of white adipose tissue through activating the AMPK-PGC1alpha-Fndc5 pathway in muscle. The FASEB Journal 2013 27 5 1981 1989 10.1096/fj.12-225755
31. Sharma N., Castorena C. M., Cartee G. D., Greater insulin sensitivity in calorie restricted rats occurs with unaltered circulating levels of several important myokines and cytokines. Nutrition & Metabolism 2012 9 90 10.1186/1743-7075-9-90
32. Sanchez J., Nozhenko Y., Palou A., Rodriguez A. M., Free fatty acid effects on myokine production in combination with exercise mimetics. Molecular Nutrition & Food Research 2013 57 8 1456 1467 10.1002/mnfr.201300126
33. Vaughan R. A., Garcia-Smith R., Bisoffi M., Conn C. A., Trujillo K. A., Conjugated linoleic acid or omega 3 fatty acids increase mitochondrial biosynthesis and metabolism in skeletal muscle cells. Lipids in Health and Disease 2012 11 142 10.1186/1476-511X-11-142
34. Bordicchia M., Liu D., Amri E., Ailhaud G., Dessì-Fulgheri P., Zhang C., Takahashi N., Sarzani R., Collins S., Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes. Journal of Clinical Investigation 2012 122 3 1022 1036 10.1172/JCI59701
35. Kelly D. P., Medicine: Irisin, light my fire. Science 2012 335 6077 42 43 2-s2.0-84859507081 10.1126/science.1221688
36. Whittle A. J., Vidal-Puig A., NPs-heart hormones that regulate brown fat? Journal of Clinical Investigation 2012 122 3 804 807 2-s2.0-84857855831 10.1172/JCI62595
37. Roberts M. D., Bayless D. S., Company J. M., Jenkins N. T., Padilla J., Childs T. E., Martin J. S., Dalbo V. J., Booth F. W., Rector R. S., Laughlin M. H., Elevated skeletal muscle irisin precursor FNDC5 mRNA in obese OLETF rats. Metabolism 2013 62 8 1052 1056 10.1016/j.metabol.2013.02.002
38. Moon H. S., Dalamaga M., Kim S. Y., Polyzos S. A., Hamnvik O. P., Magkos F., Paruthi J., Mantzoros C. S., Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals. Endocrine Reviews 2013 34 3 377 412 10.1210/er.2012-1053
39. Castillo-Quan J. I., Parkin' control: regulation of PGC-1 α through PARIS in Parkinson's disease. DMM Disease Models and Mechanisms 2011 4 4 427 429 2-s2.0-79959641960 10.1242/dmm.008227
40. Cui L., Jeong H., Borovecki F., Parkhurst C. N., Tanese N., Krainc D., Transcriptional repression of PGC-1 α by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 2006 127 1 59 69 2-s2.0-33749042331 10.1016/j.cell.2006.09.015 (Pubitemid 44466642)
41. Lin J., Wu P., Tarr P. T., Lindenberg K. S., St-Pierre J., Zhang C., Mootha V. K., Jäger S., Vianna C. R., Reznick R. M., Cui L., Manieri M., Donovan M. X., Wu Z., Cooper M. P., Fan M. C., Rohas L. M., Zavacki A. M., Cinti S., Shulman G. I., Lowell B. B., Krainc D., Spiegelman B. M., Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1 α null mice. Cell 2004 119 1 121 135 2-s2.0-5344252327 10.1016/j.cell.2004.09.013 (Pubitemid 39349325)
42. Dun S. L., Lyu R. M., Chen Y. H., Chang J. K., Luo J. J., Dun N. J., Irisin-immunoreactivity in neural and non-neural cells of the rodent. Neuroscience 2013 240 155 162 10.1016/j.neuroscience.2013.02.050
43. Hashemi M. S., Ghaedi K., Salamian A., Karbalaie K., Emadi-Baygi M., Tanhaei S., Nasr-Esfahani M. H., Baharvand H., Fndc5 knockdown significantly decreased neural differentiation rate of mouse embryonic stem cells. Neuroscience 2013 231 296 304 10.1016/j.neuroscience.2012.11.041
44. Moon H. S., Dincer F., Mantzoros C. S., Pharmacological concentrations of irisin increase cell proliferation without influencing markers of neurite outgrowth and synaptogenesis in mouse H19-7 hippocampal cell lines. Metabolism 2013 62 8 1131 1136
45. Erickson K. I., Weinstein A. M., Lopez O. L., Physical activity, brain plasticity, and Alzheimer's disease. Archives of Medical Research 2012 43 8 615 621 10.1016/j.arcmed.2012.09.008
46. Mattson M. P., Energy intake and exercise as determinants of brain health and vulnerability to injury and disease. Cell Metabolism 2012 16 6 706 722
47. Huh J. Y., Panagiotou G., Mougios V., Brinkoetter M., Vamvini M. T., Schneider B. E., Mantzoros C. S., FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism 2012 61 12 1725 1738
48. Moreno-Navarrete J. M., Ortega F., Serrano M., Guerra E., Pardo G., Tinahones F., Ricart W., Fernandez-Real J. M., Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. Journal of Clinical Endocrinology & Metabolism 2013 98 4 E769 E778 10.1210/jc.2012-2749
49. Timmons J. A., Baar K., Davidsen P. K., Atherton P. J., Is irisin a human exercise gene? Nature 2012 488 E9 E10
50. Pekkala S., Wiklund P., Hulmi J. J., Ahtiainen J. P., Horttanainen M., Pollanen E., Makela K. A., Kainulainen H., Hakkinen K., Nyman K., Alen M., Herzig K. H., Cheng S., Are skeletal muscle FNDC5 gene expression and Irisin release regulated by exercise and related to health? Journal of Physiology 2013
51. Moraes C., Leal V. O., Marinho S. M., Barroso S. G., Rocha G. S., Boaventura G. T., Mafra D., Resistance exercise training does not affect plasma Irisin levels of hemodialysis patients. Hormone and Metabolic Research 2013
52. Park K. H., Zaichenko L., Brinkoetter M., Thakkar B., Sahin-Efe A., Joung K. E., Tsoukas M., Geladari E. V., Young H. J., Dincer F., Davis C. R., Crowell J. A., Mantzoros C. S., Circulating Irisin in relation to insulin resistance and the metabolic syndrome. Journal of Clinical Endocrinology & Metabolism 2013
53. Stengel A., Hofmann T., Goebel-Stengel M., Elbelt U., Kobelt P., Klapp B. F., Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity-correlation with body mass index. Peptides 2013 39 125 130 10.1016/j.peptides.2012.11.014
54. Choi Y. K., Kim M. K., Bae K. H., Seo H. A., Jeong J. Y., Lee W. K., Kim J. G., Lee I. K., Park K. G., Serum irisin levels in new-onset type 2 diabetes. Diabetes Research and Clinical Practice 2013 100 1 96 101
55. Liu J. J., Wong M. D., Toy W. C., Tan C. S., Liu S., Ng X. W., Tavintharan S., Sum C. F., Lim S. C., Lower circulating irisin is associated with type 2 diabetes mellitus. Journal of Diabetes and its Complications 2013 27 4 365 369
56. Staiger H., Bohm A., Scheler M., Berti L., Machann J., Schick F., Machicao F., Fritsche A., Stefan N., Weigert C., Krook A., Haring H. U., de Angelis M. H., Common genetic variation in the human FNDC5 locus, encoding the novel muscle-derived "Browning" factor Irisin, determines insulin sensitivity. PLoS One 2013 8 e61903
57. Lecker S. H., Zavin A., Cao P., Arena R., Allsup K., Daniels K. M., Joseph J., Schulze P. C., Forman D. E., Expression of the irisin precursor FNDC5 in skeletal muscle correlates with aerobic exercise performance in patients with heart failure. Circulation 2012 5 812 818 10.1161/CIRCHEARTFAILURE.112. 969543
58. Wen M. S., Wang C. Y., Lin S. L., Hung K. C., Decrease in irisin in patients with chronic kidney disease. PLoS One 2013 8 e64025
59. Zhang H. J., Zhang X. F., Ma Z. M., Pan L. L., Chen Z., Han H. W., Han C. K., Zhuang X. J., Lu Y., Li X. J., Yang S. Y., Li X. Y., Irisin is inversely associated with intrahepatic triglyceride contents in obese adults. Journal of Hepatology 2013 59 3 557 562 10.1016/j.jhep.2013.04.030
60. Swick A. G., Orena S., O'Connor A., Irisin levels correlate with energy expenditure in a subgroup of humans with energy expenditure greater than predicted by fat free mass. Metabolism 2013 62 8 1070 1073
61. Kokkinos P. F., Faselis C., Myers J., Panagiotakos D., Doumas M., Interactive effects of fitness and statin treatment on mortality risk in veterans with dyslipidaemia: a cohort study. The Lancet 2013 381 9864 394 399 10.1016/S0140-6736(12)61426-3
62. Gouni-Berthold I., Berthold H. K., Huh J. Y., Berman R., Spenrath N., Krone W., Mantzoros C. S., Effects of lipid-lowering drugs on irisin in human subjects in vivo and in human skeletal muscle cells ex vivo. PLoS One 2013 8 e72858
63. Raschke S., Elsen M., Gassenhuber H., Sommerfeld M., Schwahn U., Brockmann B., Jung R., Wisloff U., Tjonna A. E., Raastad T., Hallen J., Norheim F., Drevon C. A., Romacho T., Eckardt K., Eckel J., Evidence against a beneficial effect of Irisin in humans. PLoS One 2013 8 e73680